MolMed to present Phase II trial preliminary results for its ... PharmaLive.com (press release), PA - MILAN, Italy, 16 May 2008 – MolMed SpA (MLM at MTA Italy), a biotech company focused on novel antitumour therapies, announces that preliminary results of ... |
Friday, May 16, 2008
MolMed to present Phase II trial preliminary results for its ... - PharmaLive.com (press release)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment